Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Here’s Why McKesson Corporation (MCK) Slid in Q2

2026-07-16
Janus Henderson Investors, an investment management company, released its second-quarter 2026 investor letter for the “Global Sustainable Equity Fund”. A copy of the letter can be downloaded here. Global equities experienced a robust quarter, with the Fund returning 16.17%, outperforming the Index’s 13.16% gain and the Peer Group’s 12.98% return. An overweight in information technology, particularly AI […]

Cheniere Energy (LNG) Appoints Britt Vitalone As It Reworks Key Credit Lines

2026-07-16
Cheniere Energy (NYSE:LNG) has appointed Britt Vitalone, a veteran finance leader with experience at McKesson and Align Technology, to its Board of Directors. Vitalone will serve on both the Audit and Compensation Committees, adding expertise in corporate finance, capital allocation, and governance. The company has also adjusted several revolving credit facilities, including higher commitments, extended maturities, and updated terms for subsidiary credit lines. These governance and credit...

2 Profitable Stocks Worth Investigating and 1 We Turn Down

2026-07-15
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

McKesson (MCK) Stock Dips While Market Gains: Key Facts

2026-07-14
McKesson (MCK) closed at $803.37 in the latest trading session, marking a -1.1% move from the prior day.

Cheniere Appoints Britt Vitalone to Board of Directors

2026-07-14
HOUSTON, July 14, 2026--Cheniere Appoints Britt Vitalone to Board of Directors

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

2026-07-14
McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds

2026-07-13
Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.

McKesson Releases Fiscal Year 2026 Impact Report

2026-07-13
IRVING, Texas, July 13, 2026--McKesson published its Fiscal Year 2026 Impact Report, capturing how the company is actively turning purpose into action across healthcare.

McKesson (MCK) Falls After CEO Share Sale, Is The 14% Discount Enough?

2026-07-11
McKesson (MCK) is back in focus after a 3.5% share decline following CEO Brian S. Tyler’s sale of 8,463 shares, worth about US$6.7 million, under a pre arranged trading plan. See our latest analysis for McKesson. That reaction sits against a mixed backdrop for McKesson, with the share price returning 2.5% over seven days but declining 6.9% over three months, while the 1 year total shareholder return of 14.0% and very large 5 year total shareholder return indicate that longer term momentum...

Can McKesson (MCK) Stay Cheap After A 338% Five Year Run?

2026-07-11
McKesson stock has delivered a very large 337.6% total return over the past 5 years, yet the latest valuation checks still suggest the shares lean cheap rather than stretched after that run. Over 5 years, McKesson’s 337.6% return points to a stock that has already rewarded investors heavily, so the key issue is whether today’s price still leaves room for further upside. Expectations around earnings growth supported by capital returns, including buybacks, can support today’s valuation, while...